Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen you're taking semaglutide for weight management, getting enough protein each day becomes one of the most practical questions to answer. Clinical trial data from the STEP programme showed that participants on semaglutide 2.4mg lost an average of around 15% of body weight over 68 weeks — but a meaningful portion of that loss can be lean muscle mass if protein intake is inadequate. A simple protein calculator gives you a starting target; this page explains how to use one correctly, what numbers to aim for, and why the figure changes as your weight changes on treatment. Semaglutide (Wegovy) is a prescription-only medicine; a prescriber decides whether it is clinically suitable for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, randomised 1,961 adults without diabetes to semaglutide 2.4mg or placebo for 68 weeks. Average weight loss in the active group was approximately 15%. Crucially, body composition data across the semaglutide trial programme consistently showed that a proportion of weight lost comes from lean tissue, not fat alone, a pattern common to any significant calorie deficit, with or without a GLP-1 medicine. The practical implication is straightforward: if you are losing weight quickly and eating less because your appetite is suppressed, protein becomes the nutrient most worth protecting.
UK dietary reference values set a baseline protein requirement of 0.75 g per kilogram per day for sedentary adults, but that figure was never designed for people in active weight loss. For that context, the range most consistently cited in clinical dietetic practice is 1.2–1.6 g per kilogram of goal body weight per day. Use goal body weight rather than current weight; otherwise the target rises and falls week by week, which makes meal planning harder than it needs to be. If you are doing regular resistance training alongside treatment (which genuinely helps preserve muscle) some practitioners recommend the upper end of that range or slightly above it. Discuss the right figure for your situation with your prescriber or a registered dietitian.
A practical checking habit that takes under a minute: open the food label on the main protein source in tonight's meal and divide its protein grams by your target. Do that three times over a day and you'll have a rough sense of whether you're hitting the mark without a full food diary.
Most online protein calculators ask for your current weight, height, age, sex and activity level, then return a gram figure. They work best when you feed them your goal weight rather than today's weight, for the reason above. A 75 kg goal weight at 1.4 g/kg lands at 105 g of protein per day, a figure that most people find achievable across three meals but genuinely difficult when nausea suppresses appetite at the start of a new dose.
That appetite suppression matters. One of the questions our prescribers hear regularly is why someone feels fine skipping breakfast or eating very little at lunch. Semaglutide slows gastric emptying and reduces hunger signals markedly; the result is that total calorie intake drops, but the ratio of that intake coming from protein can also drop unless you plan deliberately. Pairing your calculator output with a food-first strategy (prioritising protein at the start of each meal before appetite fades) tends to produce better outcomes than relying on willpower later in the day.
For a fuller breakdown of what your plate should look like alongside treatment, the food choices on Wegovy guide covers meal structure in practical terms. And if you want to understand whether protein shakes can help fill a gap, using protein shakes on Wegovy looks at the options and what to watch for.
Eating 100–120 g of protein a day is straightforward when you are hungry. On semaglutide, many people find they can manage only small portions, which means every bite needs to count nutritionally. The highest-protein, lowest-volume foods (things like Greek yoghurt, cottage cheese, eggs, canned fish, chicken breast, edamame and firm tofu) tend to work better than bulky whole-food options when stomach capacity feels limited.
The British Dietetic Association's food facts guidance encourages variety across animal and plant protein sources for broader nutritional benefit, not just hitting a gram target. That framing is worth holding onto: protein intake on Wegovy is not a single number to hit and forget; it is part of a broader dietary pattern that supports the physical changes treatment is driving. For anyone wondering about specific foods (peanut butter is a common one) whether peanut butter fits a Wegovy diet addresses the protein-to-calorie trade-off directly.
The NHS semaglutide patient information recommends combining treatment with a reduced-calorie diet and increased physical activity, the protein picture sits squarely inside that recommendation. Neither the medicine nor the macro target works in isolation. If you are not yet on treatment and want to understand the full clinical picture, the Wegovy overview explains how treatment works and what eligibility looks like in the UK. Calorie context matters too: how a calorie calculator fits around Wegovy is worth reading alongside this page.
Your protein requirement is not static. As weight falls, goal body weight may be revised downward, and if you add strength training (something worth considering at any stage) the calculation shifts again. People who have lost more than 10% of their starting weight, or who are approaching a maintenance phase, often benefit from a formal dietary review rather than continuing with the figure they calculated at the start of treatment.
There is also the question of how protein intake interacts with the medicine itself. The relationship between dietary protein, GIP and GLP-1 hormone release is an active area of research; for background on the science, whether semaglutide is itself a protein and the broader protein-and-Wegovy research summary both go deeper into the mechanism. And if you want a consolidated view of protein targets, timing and food choices in one place, protein intake on Wegovy pulls it together.
Wegovy is a prescription-only medicine. If you are considering treatment and want a same-day clinical review by a GPhC-registered prescriber, check your eligibility with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.